Following positive test results, Moderna, Inc. filed last week with the U.S. Food and Drug Administration (FDA) to expand the scope of its COVID-19 vaccine’s emergency use authorization (EUA) to include adolescents between 12 and 18 years old.
This expansion push follows the results of a... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will provide $706,534 in funding for Dascena, Inc. to further its COViage system, potentially expanding its machine learning capabilities to predict deteriorating health among hospitalized COVID-19 patients.
Hospitalized COVID-19... Read More »
On Wednesday, U.S. Sens. Jeff Merkley (D-OR) and Elizabeth Warren (D-MA) joined U.S. Reps. Raja Krishnamoorthi (D-IL) and Suzanne Bonamici (D-OR) to introduce legislation that would expand the U.S. response to the coronavirus on an international level.
The Nullifying Opportunities for Variants... Read More »
The World Health Organization (WHO) gained more than 3 million lab-confirmed infection case reports in response -- a record figure -- in response to a call issued last year for input into the Global Antimicrobial Resistance and Use Surveillance System (GLASS).
These country-by-country reports... Read More »
A new agreement struck between the Biden administration and Merck & Co. will provide the U.S. government with 1.7 million courses of the company’s investigational COVID-19 antiviral treatment, molnupiravir.
This agreement is contingent upon either emergency use authorization (EUA) or approval... Read More »
In efforts to improve the Strategic National Stockpile, the U.S. Department of Health and Human Services (HHS) awarded a $53.4 million contract to Henry Schein, Inc. this week for the storage and distribution of 80,000 pallets of personal protective equipment and COVID-19 related products.
This... Read More »
The U.S. Departments of Defense (DoD) and Health and Human Services (HHS) have awarded a $4.6 million contract to DiaSorin Inc. to boost production capacity of SARS-CoV-2 serology tests by nearly eightfold, to 10 million per month by May 2022.
Currently, the lab diagnostics company DiaSorin... Read More »
A new study from the Centers for Disease Control and Prevention (CDC) demonstrated continuing good news for mRNA COVID-19 vaccines, crediting them with reducing the risk of infection by 91 percent for those fully vaccinated by either the Pfizer-BioNTech or Moderna vaccines.
While previous... Read More »
The U.S. Food and Drug Administration (FDA) approval of Chimerix, Inc.’s smallpox therapeutic TEMBEXA last week marked a medical achievement and a milestone for the Biomedical Advanced Research and Development Authority (BARDA).
BARDA itself was created in 2006. It began collaborating with... Read More »
A professor at Georgia State University’s Institute for Biomedical Sciences, Dr. Sang-Moo Kang, received a five-year, $2.7 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) last week for a study of seasonal and universal vaccination in elderly... Read More »
In a letter to President Joe Biden last week, more than 40 U.S. representatives sought to use the impending G7 Summit as an opportunity to call for five quick, immediate actions to guarantee COVID-19 vaccines were administered worldwide.
The group, led by U.S. Reps. Pramila Jayapal (D-WA), Tom... Read More »
According to new research from National Institutes of Health (NIH) scientists at the Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the oral antiviral drug TEMPOL could limit SARS-CoV-2 infection capabilities.
Though still considered experimental, the drug’s... Read More »
Biotech company Moderna announced Tuesday that they had entered into an agreement with Thermo Fisher Scientific to fill/finish the sterile manufacturing and packaging of Moderna’s COVID-19 vaccine.
Under the agreement, Thermo Fishers’ facility in Greenville, N.C., will be used for aseptic... Read More »
With $4.2 million in funding from the Henry Jackson Foundation and a new partnership with the U.S. Naval Medical Research Center (NMRC), Centivax Inc. intends to pursue phase one clinical development of Centi-B9, a broad-spectrum injectable for treating SARS-CoV-2.
Unlike other vaccines and... Read More »
The leaders of the international organizations for financing, health, and trade are urging government leaders to finance a new $50 billion roadmap to help end the pandemic and spur global economic recovery.
Leaders of the International Monetary Fund, World Bank Group, World Health Organization,... Read More »
Basel, Switzerland-based pharmaceutical company BioVersys has secured a $4.35 million funding allotment from CARB-X to develop new antibiotics to treat life-threatening infections caused by ESKAPE pathogens.
The pathogens are identified as bacteria that have developed resistance to most current,... Read More »
Following its development by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), the U.S. National Institutes of Health (NIH) began a human, phase one clinical trial to determine the safety and immunogenicity of a nanoparticle-based, universal influenza... Read More »
U.S. Reps. Brian Fitzpatrick (R-PA) and Conor Lamb (D-PA) sought legislative action on foreign nations’ health efforts last week, introducing the Never Again International Outbreak Prevention Act to establish new monitoring and reporting mandates, sanctions, and an investigation of the World... Read More »
After months of operating under the ongoing pandemic, Moderna, Inc. announced this week that it has initiated the Biologics License Application (BLA) process with the United States Food and Drug Administration (FDA) to gain full approval of its mRNA COVID-19 vaccine.
This approval would make... Read More »
President Joe Biden’s first budget proposal would authorize the largest funding increase in nearly two decades for the Centers for Disease Control and Prevention (CDC), going above and beyond funding the agency’s disease-focused work at the U.S. Department of Health and Human Services... Read More »
Renco Corporation has secured a $13.1 million contract via the Department of Defense (DOD) and the Department of Health and Human Services (HHS) to bolster domestic nitrile gloves production.
Under the agreement, the initiative enables Renco to increase the production capacity of nitrile gloves... Read More »
Another COVID-19 vaccine may soon be on the way: Sanofi and GSK began enrollment for a phase three, global clinical study of their adjuvanted recombinant-protein vaccine candidate, with the anticipation it could be approved by the end of the year.
Approval will, of course, depend on results, and... Read More »
According to the World Health Organization (WHO), the COVID-19 pandemic situation is stabilizing in nations with advanced vaccination programs, but it is surging in other, less equipped areas, demanding action lest the future become a repeat of present failures.
WHO urges the distribution of 2... Read More »
A new collaborative effort between Battelle, a science and technology research and development firm headquartered in Columbus, Ohio; the Ohio State University; and Northwestern University hopes to combat the “infodemic” of false and misleading information online surrounding the COVID-19... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) awarded $7.1 million grant funding to an Oxford University study assessing if COVID-19 vaccine regimens can be mixed.
These funds will complement $3 million of funding already granted from the U.K. government and support from the... Read More »
The U.S. Food and Drug Administration (FDA) added another tool to the fight against COVID-19 this week, granting emergency use authorization (EUA) to the monoclonal antibody therapy sotrovimab for use against mild to moderate COVID-19 cases in those 12 years and older.
The EUA was granted to... Read More »
The nonprofit Nuclear Threat Initiative (NTI) | bio virtually convened an interdisciplinary group of experts and world leaders earlier this month to push for a global organization to reduce biotechnology risks, promote biosecurity and strengthen international oversight of life sciences... Read More »
Thanks to a $400,000 grant from The Rockefeller Foundation, the Johns Hopkins Center for Health Security will document, evaluate and spread information on large-scale health successes among the COVID-19 response in low and middle-income nations over the past year.
This information will be used... Read More »
Academia and the private sector must be in a collaborative relationship with the United States government to invest in the research and development of technologies that will prevent a future pandemic, experts said on Wednesday during a webinar hosted by the Capitol Hill Steering Committee on... Read More »
Coalition for Epidemic Preparedness Innovations (CEPI) officials said the organization has expanded its partnership with SK bioscience to develop a vaccine to combat SARS-CoV-2 and variants of concern.
The agreement calls for CEPI to earmark up to $173.4 million for SK bioscience's to COVID-19... Read More »
The AFL-CIO, the Service Employees International Union (SEIU), and the United States Footwear Manufacturers Association are among 20 union and stakeholder organizations supporting the Make PPE in America Act.
The unions and stakeholder organizations recently forwarded correspondence to Majority... Read More »
Plans are underway to submit the Moderna, Inc. COVID-19 vaccine to regulators in early June to expand its use, following positive results from a Phase 2/3 study that distributed the vaccine among adolescents aged 12 to 17 years old.
The vaccine, known as mRNA-1273, met its primary immunogenicity... Read More »
As part of a new Memorandum of Understanding between the World Health Organization (WHO) and the Swiss Confederation, the first facility in the WHO BioHub System was agreed to this week.
Such facilities, first announced in November 2020, will serve as centers for reception, sequencing, storage,... Read More »
In a letter to Homeland Security Secretary Alejandro Mayorkas written last week, Republican House Energy and Commerce Committee leaders requested two classified briefings on the origins of COVID-19 and any work conducted therein.
“[W]e strongly support a comprehensive investigation into the... Read More »
Under a new agreement announced last week, Samsung Biologics will bolster the global supply of mRNA-1273, Moderna, Inc.’s COVID-19 vaccine, by providing large-scale, commercial fill-finish manufacturing.
Technology transfer began upon execution of the deal so that Samsung Biologics could... Read More »